Millions of Americans are not taking their GLP-1 drugs as prescribed

GLP-1 medications are everywhere these days. The peptide-based drugs are both highly effective and wildly popular for diabetes, weight loss and a growing range of connected chronic health conditions, including cardiovascular disease and obstructive…
Read the full story at Ars Technica ↗
ImpactNotable
Published2 h ago (Fri, 13 Nov 2026 21:59:01 GMT)
AuthorBeth Mole
MoreLess
Impact score33/100
RatingProbability of 74%.
RegionsGlobal
Retrievedvia rss
ClassifiedFri, 13 Nov 2026 23:01:00 GMT by classifier